{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T01:50:59Z","timestamp":1780710659492,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.drugalcdep.2014.02.018","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T00:00:50Z","timestamp":1393372850000},"page":"9-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers"],"prefix":"10.1016","volume":"139","author":[{"given":"Jennifer R.","family":"Havens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl G.","family":"Leukefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela M.","family":"DeVeaugh-Geiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard D.","family":"Chilcoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archinte.162.9.981","article-title":"Forgetting, fabricating, and telescoping: the instability of the medical history","volume":"162","author":"Barsky","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0010","article-title":"Changing drug use patterns in rural Appalachia: a qualitative analysis","author":"Buer","year":"2014","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5055\/jom.2010.0022","article-title":"Characteristics of prescription opioid abusers in treatment: prescription opioid use history, age, use patterns, and functional severity","volume":"6","author":"Butler","year":"2010","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0020","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jpain.2012.08.008","article-title":"Abuse rates and routes of administration of reformulated extended-release oxycodone: initial findings from a sentinel surveillance sample of individuals assessed for substance abuse treatment","volume":"14","author":"Butler","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc1204141","article-title":"Effect of abuse-deterrent formulation of OxyContin","volume":"367","author":"Cicero","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0030","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/pds.1452","article-title":"Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States","volume":"16","author":"Cicero","year":"2007","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2012.12.006","article-title":"An iterative model for in vitro laboratory assessment of tamper deterrent formulations","volume":"131","author":"Cone","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0045","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","article-title":"Self-report among injecting drug users: a review","volume":"51","author":"Darke","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0050","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1360-0443.2005.01094.x","article-title":"Effects of a sustained heroin shortage in three Australian States","volume":"100","author":"Degenhardt","year":"2005","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0055","unstructured":"Embeda [package insert], 2012. King Pharmaceuticals Inc., Bristol, TN."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0060","series-title":"Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee Meeting Announcement","author":"FDA Advisory Committee Transcript","year":"2010"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0065","series-title":"Abuse Deterrent Opioids \u2013 Evaluation and Labeling Draft Guidance","author":"FDA Guidance for Industry","year":"2013"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0070","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1360-0443.2000.95339310.x","article-title":"Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London","volume":"95","author":"Fountain","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0075","series-title":"Eighth Conference on Health Survey Research Methods: Conference Proceedings","first-page":"29","article-title":"Estimating trends in substance use based on reports of prior use in a cross-sectional survey","author":"Gfroerer","year":"2004"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0080","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.2105\/AJPH.2012.300874","article-title":"Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users","volume":"103","author":"Havens","year":"2013","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5055\/jom.2008.0010","article-title":"Prescription opioid use in the rural Appalachia: a community-based study","volume":"4","author":"Havens","year":"2008","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugalcdep.2006.07.008","article-title":"Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users","volume":"87","author":"Havens","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00952990601175078","article-title":"Differences in prevalence of prescription opiate misuse among rural and urban probationers","volume":"33","author":"Havens","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1300\/J069v23n04_01","article-title":"A profile of OxyContin addiction","volume":"23","author":"Hays","year":"2004","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0105","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/00952990.2011.569623","article-title":"Tampering with prescription opioids: nature and extent of the problem, health consequences, and solutions","volume":"37","author":"Katz","year":"2011","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0376-8716(97)01339-2","article-title":"Reliability of drug dependents\u2019 self-reports","volume":"45","author":"Kokkevi","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.drugpo.2011.11.002","article-title":"Scale-up of opioid substitution therapy in India: opportunities and challenges","volume":"23","author":"Kumar","year":"2012","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1081\/JA-120004282","article-title":"Drug use and AIDS: estimating injection prevalence in a rural state","volume":"37","author":"Leukefeld","year":"2002","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","article-title":"The fifth edition of the addiction severity index","volume":"9","author":"McLellan","year":"1992","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0135","series-title":"2012 National Drug Control Strategy","author":"Office of National Drug Control Policy","year":"2012"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0140","series-title":"Prescription Drug Abuse","author":"Office of National Drug Control Policy","year":"2012"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0145","unstructured":"Opana [package insert], 2011. Novartis Consumer Health, Lincoln, NE."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0150","unstructured":"OxyContin [package insert], 2013. Purdue Pharma L.P., Stamford, CT."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s40261-013-0085-x","article-title":"Pharmacokinetics, tolerability, and safety of intranasal administration of reformulated OxyContin\u00ae tablets compared with original OxyContin\u00ae tablets in healthy adults","volume":"33","author":"Perrino","year":"2013","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0160","doi-asserted-by":"crossref","DOI":"10.1177\/0269881113493364","article-title":"Attractiveness of reformulated OxyContin(R) tablets: assessing comparative preferences and tampering potential","author":"Sellers","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2013.04.011","article-title":"Reduced abuse, therapeutic errors, and diversion following reformulation of extended-release Oxycodone in 2010","author":"Severtson","year":"2013","journal-title":"J. Pain"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0170","first-page":"22","article-title":"The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0175","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1360-0443.2006.01367.x","article-title":"Opiate addiction in China: current situation and treatments","volume":"101","author":"Tang","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0180","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1360-0443.2011.03635.x","article-title":"Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis","volume":"107","author":"Young","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0185","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3109\/00952990.2011.643971","article-title":"A comparison of rural and urban nonmedical prescription opioid users\u2019 lifetime and recent drug use","volume":"38","author":"Young","year":"2012","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-7517-7-24","article-title":"Route of administration for illicit prescription opioids: a comparison of rural and urban drug users","volume":"7","author":"Young","year":"2010","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0195","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0376-8716(03)00003-6","article-title":"College on problems of drug dependence taskforce on prescription opioid non-medical use and abuse: position statement","volume":"69","author":"Zacny","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2014.02.018_bib0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2307\/2531248","article-title":"Longitudinal data analysis for discrete and continuous outcomes","volume":"42","author":"Zeger","year":"1986","journal-title":"Biometries"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614000738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871614000738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:59:52Z","timestamp":1565207992000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871614000738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":40,"alternative-id":["S0376871614000738"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.02.018","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}